Vol 6 n° 1 - Predictors of Response to Treatment in Neuropsychiatry
Past issues Contributors How to publish Contributions and comments Home
 
C o n t e n t s 3 ISSUE COORDINATED BY: Jean-Paul MACHER Editorial Jean-Paul Macher, Marc-Antoine Crocq State of the art Genetic variation and pharmacogenomics: concepts, facts, and challenges Margret R. Hoehe, Thomas Kroslak Basic research The future of genetic testing for drug response Deborah J. Morris-Rosendahl, Bernd L. Fiebich Pharmacological aspects Sex-dependent modulation of treatment response David R. Rubinow, Molly Moore Current perspectives in the management of treatment-resistant depression Rajesh M. Parikh, Barry D. Lebowitz Treatment-refractory schizophrenia Asaf Caspi, Michael Davidson, Carol A. Tamminga Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects Manfred Ackenheil, Klaus Weber Poster Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment Jean-Paul Macher, Rémy Luthringer, Luc Staner Clinical research Treatment goals: response and nonresponse Jean-Paul Macher, Marc-Antoine Crocq Poor response to treatment: beyond medication César Carvajal Clinicians’ predictions of patient response to psychotropic medications Pierre Schulz, Patricia Berney